Asthma Technology
... From a market analysis standpoint, the potential pharmaceutical market for a novel asthma therapy would comprise those that have been diagnosed with asthma at some point in their lives (diagnosed population) reduced by the number of asthmatics that are asymptomatic and therefore no longer seeking re ...
... From a market analysis standpoint, the potential pharmaceutical market for a novel asthma therapy would comprise those that have been diagnosed with asthma at some point in their lives (diagnosed population) reduced by the number of asthmatics that are asymptomatic and therefore no longer seeking re ...
Chapter 3: Effects Of Amphetamine-Type Stimulants
... As already noted, investigating psychiatric problems associated with ecstasy is difficult due to high rates of polydrug use among those presenting with psychiatric symptoms and the possibility of pre-existing problems. To date, most research has investigated the proposed link between MDMA use and de ...
... As already noted, investigating psychiatric problems associated with ecstasy is difficult due to high rates of polydrug use among those presenting with psychiatric symptoms and the possibility of pre-existing problems. To date, most research has investigated the proposed link between MDMA use and de ...
TECHtalk CE - Teva Pharmacy Solutions
... outpatient pharmacy practice) is described as the difference between what physicians prescribe and what patients are actually taking at home.(2) The physiologic, including pharmacokinetic and pharmacodynamic, changes in elderly patients’ bodies may make them more sensitive to medications and prone t ...
... outpatient pharmacy practice) is described as the difference between what physicians prescribe and what patients are actually taking at home.(2) The physiologic, including pharmacokinetic and pharmacodynamic, changes in elderly patients’ bodies may make them more sensitive to medications and prone t ...
Current Therapeutic Options in Type 2 Diabetes Mellitus: A Practical
... leads to insulin secretion.7 As the second generation SUs are currently the most widely used, this discussion will be limited to these agents. The dosing, and the cost and effect of the SUs on HbA1c are summarized in table 1. As is apparent, their relative potency is similar. The most common side ef ...
... leads to insulin secretion.7 As the second generation SUs are currently the most widely used, this discussion will be limited to these agents. The dosing, and the cost and effect of the SUs on HbA1c are summarized in table 1. As is apparent, their relative potency is similar. The most common side ef ...
lithicarb
... cases, and is probably useful as treatment, especially if there is a family history of manic depressive illness and response to lithium. In some cases of schizo-affective illness and so called chronic schizophrenia it is dramatically effective. Those in the latter category who do respond have freque ...
... cases, and is probably useful as treatment, especially if there is a family history of manic depressive illness and response to lithium. In some cases of schizo-affective illness and so called chronic schizophrenia it is dramatically effective. Those in the latter category who do respond have freque ...
Martindale: The Complete Drug Reference
... ) has been shown in various studies,1-6 two of which2,5 were ...
... ) has been shown in various studies,1-6 two of which2,5 were ...
draft report - Canadian Ophthalmological Society
... medicinal product is frequently associated with a dearth of clinical evidence regarding the effects of the product in populations that are not covered by the regulatory approval, this is not the case for bevacizumab, for which there is a relatively substantive evidence base available across several ...
... medicinal product is frequently associated with a dearth of clinical evidence regarding the effects of the product in populations that are not covered by the regulatory approval, this is not the case for bevacizumab, for which there is a relatively substantive evidence base available across several ...
Full Text - Int J Endocrinol Metab
... side effect of thionamides, that has been reported to affect 0.3% to 0.5% of patients treated with these agents.1-9 Factors or clinical circumstances that might predispose to antithyroid-associated agranulocytosis remain largely unknown.1-4,11 Agranulocytosis occurs almost exclusively during the fir ...
... side effect of thionamides, that has been reported to affect 0.3% to 0.5% of patients treated with these agents.1-9 Factors or clinical circumstances that might predispose to antithyroid-associated agranulocytosis remain largely unknown.1-4,11 Agranulocytosis occurs almost exclusively during the fir ...
Clinical Perspectives on the Applicability of “ACOA” as a Diagnosis
... 1989, and five in 1990, after which the number declined to zero by 2003 (Appendix B). By then, the terms “codependency” and “ACoA” had entered both the public’s and mental health clinicians’ lexicons despite scholarly criticism (Gomberg, 1989) and a continued lack of clear empirical support (Harter, ...
... 1989, and five in 1990, after which the number declined to zero by 2003 (Appendix B). By then, the terms “codependency” and “ACoA” had entered both the public’s and mental health clinicians’ lexicons despite scholarly criticism (Gomberg, 1989) and a continued lack of clear empirical support (Harter, ...
1 RESPIRATORY DRUGS Lois E Brenneman, MSN, ANP, FNP, C
... * used for preterm labor since it nonselectively affects smooth muscle ** potent but less used due to high side effect profile ...
... * used for preterm labor since it nonselectively affects smooth muscle ** potent but less used due to high side effect profile ...
Zonisamide (Zonegran®) Clinicians initiating this medication should
... Despite the number of antiepileptic drugs currently available, a significant proportion of patients (up to 1/3) continue to suffer with seizures. Zonisamide (Zonegran®) is a benzisoxazole derivative – chemically unrelated to other antiepileptic drugs. It has multiple mechanisms of action including i ...
... Despite the number of antiepileptic drugs currently available, a significant proportion of patients (up to 1/3) continue to suffer with seizures. Zonisamide (Zonegran®) is a benzisoxazole derivative – chemically unrelated to other antiepileptic drugs. It has multiple mechanisms of action including i ...
Didanosine - WHO archives - World Health Organization
... counts. Twenty-three secondary clinic events during the study were reported, including 6 deaths (4 TB-related, 1 cryptococcal meningitis, 1 non-Hodgkin’s lymphoma) — an AIDS-associated mortality rate of 5.7% at six months. This program was also significant for the fact that it relied on generic drug ...
... counts. Twenty-three secondary clinic events during the study were reported, including 6 deaths (4 TB-related, 1 cryptococcal meningitis, 1 non-Hodgkin’s lymphoma) — an AIDS-associated mortality rate of 5.7% at six months. This program was also significant for the fact that it relied on generic drug ...
Hallucinogens - Multidisciplinary Association for Psychedelic Studies
... There is only a meager amount of factual information about hallucinogenic drugs among the general public today. Furthermore, in the scientific and medical communities, where one expects to find expertise on drugs, there is now a whole generation who knows almost nothing about hallucinogens other tha ...
... There is only a meager amount of factual information about hallucinogenic drugs among the general public today. Furthermore, in the scientific and medical communities, where one expects to find expertise on drugs, there is now a whole generation who knows almost nothing about hallucinogens other tha ...
Consent for treatment with Buprenorphine
... Some patients find that it takes several days to get used to the transition from the opioid they had been using to buprenorphine. During that time, any use of other opioids may cause an increase in symptoms. After you become stabilized on buprenorphine, it is expected that other opioids will have le ...
... Some patients find that it takes several days to get used to the transition from the opioid they had been using to buprenorphine. During that time, any use of other opioids may cause an increase in symptoms. After you become stabilized on buprenorphine, it is expected that other opioids will have le ...
Dynacin Prescribing Information
... The anti-anabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired function, higher serum levels of tetracycline may lead to azotemia, hyperphosphatemia, and acidosis. If renal impairmen ...
... The anti-anabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired function, higher serum levels of tetracycline may lead to azotemia, hyperphosphatemia, and acidosis. If renal impairmen ...
Provision of Clinical Pharmacist Services for Individuals
... DAAs can potentiate these toxicities as well as incur new toxicities.10, 12 Although ribavirin dose reduction is the preferred initial management strategy, severe anemia could necessitate the use of erythropoietin-stimulating agents (ESAs) and transfusions and/or result in hospitalization.10, 12 For ...
... DAAs can potentiate these toxicities as well as incur new toxicities.10, 12 Although ribavirin dose reduction is the preferred initial management strategy, severe anemia could necessitate the use of erythropoietin-stimulating agents (ESAs) and transfusions and/or result in hospitalization.10, 12 For ...
Newsletter What’s Inside
... It is hard to believe that another year is fast approaching its end, and by all accounts 2012 has been a very busy and hopefully a successful year for CRS and its members. By all accounts the meeting in Canada was a great success and all who attended had an excellent social and importantly a signifi ...
... It is hard to believe that another year is fast approaching its end, and by all accounts 2012 has been a very busy and hopefully a successful year for CRS and its members. By all accounts the meeting in Canada was a great success and all who attended had an excellent social and importantly a signifi ...
(2014). Treating comorbid - Scientific Research Publishing
... Assessment was based on the data of 63 patients (47 female, 16 male) aged between 58 and 90 years (average age 66.6 years) diagnosed with primary or secondary non-organic insomnia (F51.0) who participated in group sleep treatment for older adults. The 63 patients were recruited from seven treatment ...
... Assessment was based on the data of 63 patients (47 female, 16 male) aged between 58 and 90 years (average age 66.6 years) diagnosed with primary or secondary non-organic insomnia (F51.0) who participated in group sleep treatment for older adults. The 63 patients were recruited from seven treatment ...
Long-acting beta2- adrenoreceptor agonists: salmeterol and
... agonists, with relaxant effects on bronchial smooth muscle in vitro. However, some significant pharmacological differences between these drugs have been documented in vitro and in patients, as shown in Table 1.2 Formoterol has a more rapid onset of action than salmeterol, which may make formoterol s ...
... agonists, with relaxant effects on bronchial smooth muscle in vitro. However, some significant pharmacological differences between these drugs have been documented in vitro and in patients, as shown in Table 1.2 Formoterol has a more rapid onset of action than salmeterol, which may make formoterol s ...
Updated Guidelines on Outpatient Anticoagulation
... is not within the desired therapeutic range after excluding explanatory factors, a 5 to 20 percent increase or decrease in the total weekly dosage is required.4-6 Patients should be provided with the simplest regimen to achieve the new total weekly dosage. Drug, Food, and Disease State Interactions. ...
... is not within the desired therapeutic range after excluding explanatory factors, a 5 to 20 percent increase or decrease in the total weekly dosage is required.4-6 Patients should be provided with the simplest regimen to achieve the new total weekly dosage. Drug, Food, and Disease State Interactions. ...
IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT)
... half-life of 2-4h. It is highly lipid soluble and has a distribution half-life of approximately 7-11 min. Ketamine is metabolized to at least two compounds: first by N-demethylation, to norketamine, which has 1/3-1/2 of the potency of ketamine. Norketamine is further dehydrogenated to produce dehydr ...
... half-life of 2-4h. It is highly lipid soluble and has a distribution half-life of approximately 7-11 min. Ketamine is metabolized to at least two compounds: first by N-demethylation, to norketamine, which has 1/3-1/2 of the potency of ketamine. Norketamine is further dehydrogenated to produce dehydr ...
Dopa-responsive Dystonia in Children
... dystonias responding to levodopa. The most common form of DRD is an autosomal-dominant condition caused by mutation of the gene for guanosine triphosphate (GTP) cyclohydrolase I [3]. Guanosine triphosphate cyclohydrolase I is the rate-limiting and initial step in the biosynthesis of tetrahydrobiopte ...
... dystonias responding to levodopa. The most common form of DRD is an autosomal-dominant condition caused by mutation of the gene for guanosine triphosphate (GTP) cyclohydrolase I [3]. Guanosine triphosphate cyclohydrolase I is the rate-limiting and initial step in the biosynthesis of tetrahydrobiopte ...
Meta-analysis of Oral Triptan Therapy for Migraine: Number Needed
... initial dosing, was then calculated for Note: Comparisons versus rizatriptan 10 mg: sumatriptan 100 mg, zolmitriptan 2.5 mg (P<0.05 for both), sumaeach triptan by multiplying the NNT by triptan 50 mg, almotriptan 12.5 mg, (P<0. 01 for all), naratriptan 2.5 mg (P<0.001), and frovatriptan 2.5 mg the c ...
... initial dosing, was then calculated for Note: Comparisons versus rizatriptan 10 mg: sumatriptan 100 mg, zolmitriptan 2.5 mg (P<0.05 for both), sumaeach triptan by multiplying the NNT by triptan 50 mg, almotriptan 12.5 mg, (P<0. 01 for all), naratriptan 2.5 mg (P<0.001), and frovatriptan 2.5 mg the c ...
NIDA Research Report - MDMA
... Myths abound about both the acute effects and long-term consequences of this drug, often called ecstasy or “X.” Indeed, one reason for the rapid rise in the drug’s popularity is that many young people believe that MDMA is a new safe drug. But MDMA is not new to the scientific community, as many labo ...
... Myths abound about both the acute effects and long-term consequences of this drug, often called ecstasy or “X.” Indeed, one reason for the rapid rise in the drug’s popularity is that many young people believe that MDMA is a new safe drug. But MDMA is not new to the scientific community, as many labo ...